Scholarlink

<p>Human papillomaviruses (HPV) are widespread and cause numerous new cases of cancer each year, particularly genital and oropharyngeal cancers. The HPV vaccination has been available since 2006 and is recommended in Germany from the age of 9 years.&#xa0;Nevertheless, vaccination rates remain below the targeted goals. Early vaccination must precede sexual contact to elicit optimal protective effects. Studies show that the highest effectiveness is achieved when the vaccination series is completed before the 14th&#xa0;birthday. Children vaccinated early exhibit particularly strong immune responses and stable antibody levels. Linking the vaccination to routine childhood check-ups can improve coverage. Furthermore, the vaccination protects not only girls but also boys against HPV-associated diseases, such as anal and penile cancers. International registry studies confirm a&#xa0;significant reduction in HPV-related disease burden where the vaccination rate is high. Early HPV vaccination provides clear immunological, epidemiological and organizational advantages. A&#xa0;nationwide check-up at ages 9–10 years represents an effective opportunity for vaccination counselling and administration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

HPV-Impfung ab 9 Jahren: warum frühzeitig impfen sinnvoll ist

  • 期刊论文

  • 发表日期：

    2025年11月28日

查看全文
  • Herbert Grundhewer,
  • Julia Tabatabai,
  • Herbert Grundhewer,
  • Ulrich Heininger,
  • Henriette Högl,
  • Ulrike Horacek,
  • Hans-Iko Huppertz,
  • Markus Knuf,
  • Georg-Christoph Korenke,
  • Andreas Müller,
  • Julia Tabatabai,
  • Ulrich v. Both

摘要

Human papillomaviruses (HPV) are widespread and cause numerous new cases of cancer each year, particularly genital and oropharyngeal cancers. The HPV vaccination has been available since 2006 and is recommended in Germany from the age of 9 years. Nevertheless, vaccination rates remain below the targeted goals. Early vaccination must precede sexual contact to elicit optimal protective effects. Studies show that the highest effectiveness is achieved when the vaccination series is completed before the 14th birthday. Children vaccinated early exhibit particularly strong immune responses and stable antibody levels. Linking the vaccination to routine childhood check-ups can improve coverage. Furthermore, the vaccination protects not only girls but also boys against HPV-associated diseases, such as anal and penile cancers. International registry studies confirm a significant reduction in HPV-related disease burden where the vaccination rate is high. Early HPV vaccination provides clear immunological, epidemiological and organizational advantages. A nationwide check-up at ages 9–10 years represents an effective opportunity for vaccination counselling and administration.